JP2015530868A5 - - Google Patents

Download PDF

Info

Publication number
JP2015530868A5
JP2015530868A5 JP2015520775A JP2015520775A JP2015530868A5 JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5 JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015520775 A JP2015520775 A JP 2015520775A JP 2015530868 A5 JP2015530868 A5 JP 2015530868A5
Authority
JP
Japan
Prior art keywords
ifi27
level
gene product
patient
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520775A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015530868A (ja
JP6097388B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/000765 external-priority patent/WO2014008545A1/en
Publication of JP2015530868A publication Critical patent/JP2015530868A/ja
Publication of JP2015530868A5 publication Critical patent/JP2015530868A5/ja
Application granted granted Critical
Publication of JP6097388B2 publication Critical patent/JP6097388B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520775A 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化 Expired - Fee Related JP6097388B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902954A AU2012902954A0 (en) 2012-07-10 Risk stratification in influenza
AU2012902954 2012-07-10
PCT/AU2013/000765 WO2014008545A1 (en) 2012-07-10 2013-07-10 Risk stratification in influenza

Publications (3)

Publication Number Publication Date
JP2015530868A JP2015530868A (ja) 2015-10-29
JP2015530868A5 true JP2015530868A5 (enExample) 2016-06-16
JP6097388B2 JP6097388B2 (ja) 2017-03-15

Family

ID=49915252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520775A Expired - Fee Related JP6097388B2 (ja) 2012-07-10 2013-07-10 インフルエンザにおけるリスクの階層化

Country Status (10)

Country Link
US (2) US10036075B2 (enExample)
EP (1) EP2872891B1 (enExample)
JP (1) JP6097388B2 (enExample)
KR (1) KR20150040289A (enExample)
CN (1) CN104769430B (enExample)
AU (1) AU2013289854B2 (enExample)
BR (1) BR112015000685A2 (enExample)
CA (1) CA2877400A1 (enExample)
DK (1) DK2872891T3 (enExample)
WO (1) WO2014008545A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2863819C (en) 2012-02-09 2021-11-23 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
WO2015103664A1 (en) * 2014-01-09 2015-07-16 Nepean Blue Montains Local Health District Risk stratification in influenza
CN111624346A (zh) 2014-08-14 2020-09-04 米密德诊断学有限公司 用于预测及/或决定预后的套组
CA2968650A1 (en) 2014-12-11 2016-06-16 Memed Diagnostics Ltd. Marker combinations for diagnosing infections and methods of use thereof
EP3146974A1 (en) 2015-09-25 2017-03-29 Universite Claude Bernard - Lyon 1 Biomarkers for early determination of severity of influenza related disease
US11466331B2 (en) 2016-03-03 2022-10-11 Memed Diagnostics Ltd. RNA determinants for distinguishing between bacterial and viral infections
WO2017149547A1 (en) * 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
CA3027341A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
EP3519833B1 (en) 2016-09-29 2024-08-14 MeMed Diagnostics Ltd. Methods of prognosis and treatment
US12344893B2 (en) 2018-06-05 2025-07-01 Washington University Nasal genes used to identify, characterize, and diagnose viral respiratory infections
CN115136009A (zh) * 2020-04-09 2022-09-30 B.R.A.H.M.S有限公司 用于呼吸道感染诊断的生物标志物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792626A (en) * 1996-09-18 1998-08-11 Incyte Pharmaceuticals, Inc. Human interferon-inducible protein
US6821724B1 (en) * 1998-09-17 2004-11-23 Affymetrix, Inc. Methods of genetic analysis using nucleic acid arrays
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
WO2005068664A2 (en) * 2004-01-09 2005-07-28 The Regents Of The University Of California Cell-type-specific patterns of gene expression
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
WO2007034280A2 (en) * 2005-09-19 2007-03-29 Moshe Amihood Blay Composition and method for prevention of influenza
US20080171323A1 (en) * 2006-08-11 2008-07-17 Baylor Research Institute Gene Expression Signatures in Blood Leukocytes Permit Differential Diagnosis of Acute Infections
CN102112878A (zh) * 2008-06-06 2011-06-29 国立大学法人富山大学 用于检测流感病毒的装置
EP2808402A3 (en) * 2008-12-29 2015-03-25 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Methods of predicting responsiveness to interferon treatment
US20120077767A1 (en) * 2009-05-26 2012-03-29 Zaas Aimee K Molecular predictors of fungal infection
US20140004565A1 (en) 2009-07-06 2014-01-02 Alnylam Pharmaceuticals, Inc. Cell-based bioprocessing
US20120214705A1 (en) * 2009-09-28 2012-08-23 The Regents Of The University Of California Office of Technology, Beta-defensin 2 genetic variation predicts h. pylori susceptibility
WO2013030841A1 (en) * 2011-09-04 2013-03-07 Yissum Research Development Company Of The Hebrew Universitiy Of Jerusalem Ltd. Prognostic methods and compositions for predicting interferon treatment eficacy in a subject

Similar Documents

Publication Publication Date Title
JP2015530868A5 (enExample)
TWI329742B (enExample)
US10895572B2 (en) Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients
JP2017184729A5 (enExample)
JP6755241B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP6755242B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP2020516888A5 (enExample)
JP6755240B2 (ja) 新規分子バイオマーカーを使用して慢性閉塞性肺疾患(copd)を診断する方法
JP2012512389A5 (enExample)
KR20110014979A (ko) 항바이러스 요법
CN108449999B (zh) 使用色酰胺-tRNA合成酶诊断感染病或其并发症的组合物以及检测诊断标记物的方法
Guan et al. Epidemiological investigation of feline infectious peritonitis in cats living in Harbin, Northeast China from 2017 to 2019 using a combination of an EvaGreen-based real-time RT-PCR and serum chemistry assays
JP2017519498A5 (enExample)
JP7463351B2 (ja) 脳卒中の血液バイオマーカー
JP2013508719A5 (enExample)
JP2015505245A (ja) 川崎病のためのバイオマーカー
JP2015505245A5 (enExample)
Ghazzi et al. Impact of SARS-COV-2 variants on the infection severity among Iraqi patients
JP6420475B2 (ja) 細気管支炎後の喘息の診断のためのマーカーおよびその用途
JP2008167714A (ja) 川崎病発症のリスク因子
CN110331208A (zh) 分子靶标在肺腺癌联合诊断中的应用
JP2008547006A5 (enExample)
Kaysheva et al. Mass spectrometric detection of the amino acid sequence polymorphism of the hepatitis C virus antigen
JP2012521549A5 (enExample)
JP2005291899A (ja) 心疾患の検査法